Cargando…
Nonnegative principal component analysis for mass spectral serum profiles and biomarker discovery
BACKGROUND: As a novel cancer diagnostic paradigm, mass spectroscopic serum proteomic pattern diagnostics was reported superior to the conventional serologic cancer biomarkers. However, its clinical use is not fully validated yet. An important factor to prevent this young technology to become a main...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009481/ https://www.ncbi.nlm.nih.gov/pubmed/20122180 http://dx.doi.org/10.1186/1471-2105-11-S1-S1 |